Skip to main content
. 2020 Jun 19;2020:3126182. doi: 10.1155/2020/3126182

Figure 2.

Figure 2

Apatinib inhibits the invasion of HepG2, Hep3B, Huh7, and SMMC-7721 cells. Results of transwell invasion assays of Hep3B, HepG2, Huh7, and SMMC-7721 cells following treatment with apatinib for 24 h (original magnification, ×200). Quantification of the invasion in Hep3B, HepG2, Huh7, and SMMC-7721 cells (∗∗ indicates p < 0.01 vs. 0 μmol/L (control)).